SUMMARY Silicone oil alone or as an adjunct to vitrectomy is widely used for the treatment of retinal detachment complicated by proliferative vitreoretinopathy (PVR). It appears to reduce the tendency for recurrent traction detachment, but the mechanism of this action is obscure. We have studied the effects of silicone oil in an experimental animal model. Twenty five thousand homologous fibroblasts were injected into the aphakic vitrectomised rabbit eye, and traction detachment of the vascularised retina (medullary rays) regularly resulted. Intraocular silicone oil did not influence the development of this experimental detachment. 
The treatment of proliferative vitreoretinopathy (PVR) involves the use of vitrectomy and membrane segmentation techniques or the injection of silicone oil. Different success rates have been reported for vitrectomy, but in general surgical results in established PVR remain poor. ' Although reattachment of the retina can be regularly achieved, detachment frequently recurs, and extensive membrane reproliferation leads to inoperable contraction ofthe retina.
Several techniques have been suggested to augment vitrectomy and prevent recurrent detachment. Most clinical experience has been obtained with a combination of vitrectomy and silicone injection.2 Silicone oil reduces the extent of recurrence, but the explanation of this effect is unclear.
We considered that silicone oil might have a direct influence on the proliferation of membranes on the retinal surface. It is known that the growth of cells in culture is dependent upon their shape and adhesion to the underlying substrate3 and that cells in silicone oil 'round up' and cease to proliferate.4 Clinical assessment of our hypothesis was obscured by the heterogeneity of PVR. Therefore we studied this possibility using a model of traction detachment in the vitrectomised eye of an experimental animal. 
Materials and methods

VITRECTOMY AND LENSECTOMY
Pigmented rabbits weighing from 2*5-3 5 kg were sedated with intramuscularly administered KCI (20 mg/kg of body weight), acepromazine (2 mg/kg of body weight), and 1.0 ml of atropine sulphate to reduce bronchial secretions. Supplemental analgesia was provided by a retrobulbar injection of 1% lignocaine hydrochloride. The pupil was dilated with 1% tropicamide, 10% phenylephrine, and 1% atropine. The eye was gently proptosed and exposure maintained by taping the lids. Surgery was carried out under clean but not sterile conditions with the magnification of a Zeiss OPMI 6 operating microscope. Two small conjunctival peritomies were made at the 11 and 4 o'clock positions. A sclerotomy was made with a 20 gauge needle 1 mm posterior to the limbus at the 4 o'clock meridian. A pars plana cannula attached to a solution of balanced salt was inserted via this sclerotomy and secured with a 5-0 Dexon suture. To maintain pupillary dilatation 0-1 ml of 1:1000 adrenaline chloride was injected into the anterior chamber.
The second sclerotomy was made with a 20 gauge needle 1 mm posterior to the limbus at the 11 o'clock position. The needle was directed into the lens and the nucleus partially disrupted. A Shock Phako fragmenter was used to remove the bulk of the lens. The fragmenter was then withdrawn and replaced with the Ocutome probe. The majority of the lens cortex was cut and aspirated. However, some peripheral lens cortex remained. The anterior capsule of the lens was preserved, but its epithelium was removed by gently rubbing the capsule with the tip of the Ocutome probe. The Ocutome probe was then moved into the vitreous cavity and an extensive vitrectomy was performed. No attempt was made to peel the cortical vitreous.
The probe was then withdrawn and the sclerotomy closed with an 8-0 nylon suture. A similar suture was used to close the pars plana infusion site. We injected 15 mg of gentamicin sulphate and 1 mg of dexamethasone phosphate subconjunctivally. An ointment containing polymyxin B, bacitracin, and neomycin, and an atropine ointment were administered.
Provided the anterior capsule was intact postoperative inflammation rapidly subsided, and the pupil could be easily dilated. The eyes were observedintermittently by the indirect ophthalmoscope. If no detachment developed, they were submitted for the second stage of the experiment.
FIBROBLAST TISSUE CULTURE Homologous fibroblasts were established from skin biopsy specimens cultured in Dulbecco's minimal essential medium supplemented with 20% fetal bovine serum, 50 ig/ml gentamicin sulphate, 10000 U/ml penicillin and streptomycin, and 5 ig/ml of amphotericin B. The techniques were similar to those described previously.5 The cultures were incubated at 37°C in a humidified atmosphere of 5% carbon dioxide in air. At confluence the cultures were trypsinised, centrifuged, and resuspended in culture media. Aliquots of cells were removed to determine cell concentration in a Coulter counter and to determine cell viability by the trypan blue exclusion test. Viability was never below 95%. The reliability of the dose was estimated by means of additional aliquots from the same syringe. The mean value of the desired dose varied by plus or minus 5%.
FIBROBLAST INJECTION
A 20 gauge cannula attached to an infusion line was inserted through the pars plana. A second sclerotomy was made in the superior pars plana. The Ocutome probe was used to polish the anterior capsule and create an optically clear zone. Any remaining posterior cortical vitreous was also excised. At this point the Ocutome probe was removed, and via the same sclerotomy a gas fluid exchange was performed with a flute needle. The vitreous cavity was filled with a mixture of 50% SF6 and air. The flute needle was then removed and, again via the same sclerotomy, 25000 homologous fibroblasts in 0 1 ml of culture medium were slowly injected into the gas bubble through a 20 gauge needle. The cells fell through the gas bubble and formed a fluid level on the medullary rays (Fig. la) . Fifteen eyes which did not have further procedures, for example, injection of silicone, were used as controls. In the remaining 15 eyes the gas-air mixture was exchanged for silicone oil (Fig. lb) association with detachment of the posterior vitreous. These eyes and those that developed rhegmatogenous retinal detachment were excluded from this study. After the second procedure the eyes again became my the postoperative inflamed, but provided the anterior capsule was The corneas remained intact the cornea remained clear, and the anterior d. In some eyes it was chamber inflammation subsided.
In both the silicone injected and control eyes we noted the development of membranes after a period of a week to 10 days (Fig. 2) . Characteristically these began as either localised pucker adjacent to the disc or contraction of the rays in the region of the disc. In 2 control eyes and 3 eyes filled with silicone progressive traction detachment did not occur (grade 1) (Fig. 3 ). Clinically the membranes produced in both groups appeared to be similar and could be clearly seen forming behind the oil bubble in those eyes that contained silicone. The time sequence and severity of the traction detachment appeared to be the same in ;^* the control eyes and in those that contained a permanent globule of silicone. We found no clinical difference between the development of membrane in those eyes in which the vitreous cavity was filled with silicone and the control eyes in which the cavity was filled with a mixture of SF6 and air. In both groups there was little visible change for several days after the fibroblast injection. The first indication of cell growth was frequently the appearance of localised pucker adjacent to the disc or a grey nodule in the centre of the disc. In most of the eyes of both groups progressive traction detachment of the retina developed over a period of one week to 10 days culminating in gross elevation of both medullary rays, but in the majority of cases without detachment of the surrounding retina.
Was the silicone oil in contact with the developing fibroblasts? The assessment of the size of intraocular bubbles is difficult, 14 but in most cases it was impossible for us to visualise the lower extent of the bubble by the indirect ophthalmoscope. This implies that the vitreous cavity was at least 80-90% filled with silicone oil. Furthermore, the medullary ray region where the traction detachment develops is slightly dorsal in the rabbit eye. Silicone oil is lighter than aqueous fluid and rises to contact this region of the retina with the animal in the upright position. In the eyes filled with silicone oil characteristic shining reflexes from the traction detachment were observed.
This experiment confirms an earlier experiment15 in which larger numbers of cells were injected directly into a silicone globule. Both imply that silicone oil has no direct influence on the development of traction detachment. These results reinforce our clinical impression2 that, the therapeutic value of silicone oil is explained by mechanical factors, possibly the permanent closure of retinal breaks.
